Immunotherapy of type 1 diabetes mellitus

被引：0

作者：

Krisztina, Arapovicsne Kiss ^{[1
]}

Anna, Toth ^{[1
]}

Laszlo, Schandl ^{[1
]}

Zsofia, Kiss ^{[2
]}

Gabor, Winkler ^{[1
,3
]}

Tibor, Kis Janos ^{[1
,4
]}

机构：

[1] Eszak Budai Szent Janos Centrumkorhaz, Belgyogyaszat Diabetol 2, Budapest, Hungary

[2] Budai Irgalmasrendi Korhaz, Allergol & Immunol, Betegapolo Irgalmas Rend, Budapest, Hungary

[3] Elmeleti Egeszsegtudomanyi Int, Egeszsegtudomanyi Kar, Miskolc Egyet, Miskolc, Hungary

[4] Dios Arok 1-3, H-1125 Budapest, Hungary

来源：

ORVOSI HETILAP | 2024年 / 165卷 / 10期

关键词：

type; 1; diabetes; prevention; immunotherapy; glutamic acid decarboxylase antibody; teplizumab; TH1; BIAS; T-CELLS; INTERVENTION; PREVENTION; SECRETION; TRIAL; ONSET;

D O I：

10.1556/650.2024.33000

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 1 diabetes mellitus is an autoimmune disease with chronic progressive nature. The genetic, immunological, and initial metabolic abnormalities long precede the appearance of clinical symptoms, which brings up the possibility of delaying, preventing, or even reversing the development of the disease. Unfortunately, clinical trials aimed at the prevention of the disease did not bring resounding success for a long time. Recently, however, immunological treatment has reached the stage where the benefits of the intervention outweigh the risks associated with the treatment. Putting these options into daily practice, the possibility of delaying insulin treatment will reshape the current strategy of treating the disease and searching for high -risk patients with type 1 diabetes. The authors summarize the most essential knowledge about immunotherapy for the disease.

引用

页码：363 / 369

页数：7

共 41 条

[11] An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes [J].

Herold, Kevan C. ;

Bundy, Brian N. ;

Long, S. Alice ;

Bluestone, Jeffrey A. ;

DiMeglio, Linda A. ;

Dufort, Matthew J. ;

Gitelman, Stephen E. ;

Gottlieb, Peter A. ;

Krischer, Jeffrey P. ;

Linsley, Peter S. ;

Marks, Jennifer B. ;

Moore, Wayne ;

Moran, Antoinette ;

Rodriguez, Henry ;

Russell, William E. ;

Schatz, Desmond ;

Skyler, Jay S. ;

Tsalikian, Eva ;

Wherrett, Diane K. ;

Ziegler, Anette-Gabriele ;

Greenbaum, Carla J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) :603-613

[12] Teplizumab: First Approval [J].

Keam, Susan J. .

DRUGS, 2023, 83 (05) :439-445

[13] Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells [J].

Kent, SC ;

Chen, YH ;

Clemmings, SM ;

Viglietta, V ;

Kenyon, NS ;

Ricordi, C ;

Hering, B ;

Hafler, DA .

JOURNAL OF IMMUNOLOGY, 2005, 175 (07) :4458-4464

[14] Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus [J].

Kis, Janos ;

Engelmann, Peter ;

Farkas, Klara ;

Richman, Geoffrey ;

Eck, Shawn ;

Lolley, James ;

Jalahej, Heyam ;

Borowiec, Maciej ;

Kent, Sally C. ;

Treszl, Andras ;

Orban, Tihamer .

JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (03) :654-662

[15]

Kordonouri Olga, 2023, Lancet Diabetes Endocrinol, V11, P77, DOI 10.1016/S2213-8587(22)00391-6

[16] The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study [J].

Krischer, Jeffrey P. ;

Lynch, Kristian F. ;

Schatz, Desmond A. ;

Ilonen, Jorma ;

Lernmark, Ake ;

Hagopian, William A. ;

Rewers, Marian J. ;

She, Jin-Xiong ;

Simell, Olli G. ;

Toppari, Jorma ;

Ziegler, Anette-G. ;

Akolkar, Beena ;

Bonifacio, Ezio .

DIABETOLOGIA, 2015, 58 (05) :980-987

[17] The role of natural killer cells in the immune homeostasis of the maternal fetal interface [J].

Lakatos Kornel ;

Elias, Kevin M. ;

Berkowitz, Ross S. ;

Hasselblatt, Kathleen ;

Vegh Gyorgy ;

Fulop Vilmos .

ORVOSI HETILAP, 2022, 163 (19) :734-742

[18] PLASMAPHERESIS IN THE INITIAL TREATMENT OF INSULIN-DEPENDENT DIABETES-MELLITUS IN CHILDREN [J].

LUDVIGSSON, J ;

HEDING, L ;

LIEDEN, G ;

MARNER, B ;

LERNMARK, A .

BRITISH MEDICAL JOURNAL, 1983, 286 (6360) :176-178

[19] GAD treatment and insulin secretion in recent-onset type 1 diabetes [J].

Ludvigsson, Johnny ;

Faresjo, Maria ;

Hjorth, Maria ;

Axelsson, Stina ;

Cheramy, Mikael ;

Pihl, Mikael ;

Vaarala, Outi ;

Forsander, Gun ;

Ivarsson, Sten ;

Johansson, Calle ;

Lindh, Agne ;

Nilsson, Nils-Osten ;

Aman, Jan ;

Ortqvist, Eva ;

Zerhouni, Peter ;

Casas, Rosaura .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18) :1909-1920

[20] Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial [J].

Ludvigsson, Johnny ;

Sumnik, Zdenek ;

Pelikanova, Terezie ;

Nattero Chavez, Lia ;

Lundberg, Elena ;

Rica, Itxaso ;

Martinez-Brocca, Maria A. ;

Ruiz de Adana, Marisol ;

Wahlberg, Jeanette ;

Katsarou, Anastasia ;

Hanas, Ragnar ;

Hernandez, Cristina ;

Clemente Leon, Maria ;

Gomez-Gila, Ana ;

Lind, Marcus ;

Lozano, Marta Ferrer ;

Sas, Theo ;

Samuelsson, Ulf ;

Pruhova, Stepanka ;

Dietrich, Fabricia ;

Puente Marin, Sara ;

Nordlund, Anders ;

Hannelius, Ulf ;

Casas, Rosaura .

DIABETES CARE, 2021, 44 (07) :1604-1612

← 1 2 3 4 5 →